Japanese Biopharmas Put Price Tag on Tsunami Damages

In the two months since the 9.0 Tohoku earthquake triggered a massive tsunami that ravaged much of Japan's eastern coast, several of the country's biopharmaceutical companies have worked around the clock to assess the damages and get their facilities back into production despite power outages and crippled infrastructure.